ATOS- Atossa Therapeutics, Inc.

Name: Atossa Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Atossa Therapeutics, Inc. (ATOS) has 9 insiders with recent SEC Form 4 filings, including 9 buys and 2 sells. ATOS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CFO	Rees Heather	543.8K	$3.05M	-
CEO	Quay Steven C	339.1K	$1.90M	-
Dir	Steinhart Richard I	125.0K	$700.0K	-
Dir	Cigler Tessa	125.0K	$700.0K	-
Dir	Finn Jonathan	125.0K	$700.0K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 21, 2025	Quay Steven C	President &CEO	Buy	11,239	$0.88	$9,886.95	+422.7%	-13.9%	-
Mar 26, 2025	Remmel H. Lawrence	Director	Buy	10,000	$0.70	$7,000.00	+3,891%	+18.6%	-54.9%
Apr 10, 2024	Finn Jonathan	Director	Buy	25,000	$1.77	$44,250.00	New	-34.3%	-66.3%
Nov 15, 2023	Weaver Gregory L	Former EVP, CFO, &Director	Sell	50,000	$0.65	$32,500.00	-99.9%	+48.3%	+109.4%
Jun 20, 2023	Weaver Gregory L	EVP &CFO	Buy	50,000	$0.97	$48,500.00	+90,909%	-16.8%	+16.1%
Jul 2, 2021	Weaver Gregory L	Director	Sale+OE	107,497	$5.58	$599,833.26	-100%	-39.3%	-81.2%
Nov 15, 2017	Guse Kyle	CFO, Gen Counsel And Secretary	Buy	10,000	$0.34	$3,369.30	+116.3%	-	-
Apr 17, 2017	Remmel H. Lawrence	Director	Buy	2,500	$0.63	$1,580.00	+399.4%	-	-
Apr 1, 2016	Remmel H. Lawrence	Director	Buy	1,500	$0.33	$495.00	+16.0%	-	-
Mar 9, 2016	Quay Steven C	President &CEO	Buy	15,000	$0.37	$5,550.00	+0.3%	-	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC